GKWIM
BNGO icon

Gerber Kawasaki Wealth & Investment Management’s Bionano Genomics BNGO Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-33
Closed -$36K – 265
2022
Q3 		$36K Hold
33
– – ﹤0.01% 231
2022
Q2 		$27K Buy
+33
New +$34K ﹤0.01% 241
2021
Q4 		– Sell
-6
Closed -$20K – 392
2021
Q3 		$20K Buy
+6
New +$21K ﹤0.01% 507

Other funds holding BNGO

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's BNGO Position: Q4 2022 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Bionano Genomics (BNGO) in Q4 2022, closing a stake of 33 shares — an estimated $36K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in BNGO in Q3 2021 and held it in 3 quarters. The position peaked at $36K in Q3 2022. 143 funds tracked by Wall St. Rank hold BNGO as of Q4 2022.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Bionano Genomics position as of Q4 2022 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 33 Bionano Genomics shares in Q4 2022, an estimated $36K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Bionano Genomics in Q3 2021 and held it in 3 quarters.
  • Gerber Kawasaki Wealth & Investment Management's Bionano Genomics position peaked at $36K in Q3 2022.
  • 143 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2022.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2022, filed 8 Feb 2023.